The Role of 5-Aminolevulinic Acid (5-ALA) and Sleep
- 1 Department of Complementary and Alternative Medicine, University of Hawaii, John A. Burns School of Medicine, Honolulu, USA
- 2 Department of Complementary and Alternative Medicine, University of Hawaii, John A. Burns School of Medicine, Honolulu, USA;
- 3 Department of Geriatric Medicine, University of Hawaii, John A. Burns School of Medicine, Honolulu, USA
- 4 Department of Complementary and Alternative Medicine, University of Hawaii, John A. Burns School of Medicine, Honolulu, USA;
- 5 Department of Complementary and Alternative Medicine, University of Hawaii, John A. Burns School of Medicine, Honolulu, USA
Abstract
Objective: To determine if there is a relationship between the administration of the dietary supplement containing 5-Aminolevulinic Acid (5-ALA) and sleep. Methods: A double-blind, randomized parallel-group study was conducted. It was a 4-month study of 40 participants between the ages of 40 and 70. Males and females were recruited equally. There were 20 in each group who had existing sleep disorders. The tool used to measure participant sleep improvement included the Pittsburgh Insomnia Rating Scale-20 Question (PIRS-20). Improved sleep is reflected when the total PIRS-20 score is lower. Results: Improvement in sleep in the group taking 50 mg 5-ALA, compared to controls, was significant. The mean change, from baseline through week 6, was －5.67 units less on the sleep scale than the control group with a p value of 0.001. The mean change from week 6 to week 10 when the participant was no longer taking the supplement was 4.55 units higher than the control group with a p value of 0.062, which is of borderline significance. Conclusions: There is a relationship between the administration of dietary supplements containing 5-ALA and sleep. The results of this study suggest that 5-ALA is associated with improved sleep. The mechanism for sleep improvement needs to be explored. Further research is warranted.
- M. Reite, J. Ruddy and K. Nagel, “Concise Guide to Evaluation and Management of Sleep Disorders,” 3rd Edition, American Psychiatric Publishing, Inc., Arlington, 2002.
- S. Beale, “Biosynthesis of the Tetrapyrrole Pigment Precursor, d-Aminolevulinic Acid, from Glutamate,” Plant Physiology, Vol. 93, No. 4, 1990, pp. 1273-1279. http://dx.doi.org/10.1104/pp.93.4.1273
- M. Doss, F. Sixel-Dietrich and F. Verspohl, “Glucose Effect and Rate Limiting Function of Uroporphyrinogen Synthase on Porphyrin Metabolism in Hepatocyte Culture: Relationship with Human Acute Hepatic Porphyrias,” Journal of Clinical Chemistry & Clinical Biochemistry, Vol. 23, No. 9, 1985, pp. 505-513.
- S. Daya, K. O. Nonaka and R. J. Reiter, “Melatonin Counteracts the 5-Aminolevulinic Acidinduced Rise of Rat Forebrain Tryptophan and Serotonin Concentrations at Night,” Neuroscience Letters, Vol. 114, No. 1, 1990, pp. 113-116. http://dx.doi.org/10.1016/0304-3940(90)90437-E
- D. E. Moul, P. A. Pilkonis, J. M. Miewald, et al., “Preliminary Study of the Test-Retest Reliability and Concurrent Validities of the Pittsburgh Insomnia Rating Scale (PIRS),” Sleep, Vol. 25, Suplement S, 2002, pp. A246-A247.
- N. Cary, “SAS/STAT ® 9.2 User’s Guide,” SAS Institute Inc., Cary, 2008.
- S. Carson, M. S. McDonagh, S. Thakurta, P.-Y. Yen and M. Helfand, “Oregon Evidence-Based Practice Center,” Oregon Health & Science University, Portland, 2008.
- M. Bayard, T. Avonda and J. Wadzinski, “Restless Legs Syndrome,” American Family Physician, Vol. 78, No. 2, 2008, pp. 235-240.
- NIH, “Health Information for the Public,” National Heart, Lung and Blood Institute, US Department of Health and Human Services, 2009.
- B. L. Rodriguez, J. D. Curb, J. Davis, et al., “Use of the Dietary Supplement 5-Aminiolevulinic Acid (5-ALA) and Its Relationship with Glucose Levels and Hemoglobin A1C among Individuals with Prediabetes,” Clinical and Translational Science, Vol. 5, No. 4, 2012, pp. 314-320. http://dx.doi.org/10.1111/j.1752-8062.2012.00421.x
- S. R. Pandi-Perumal, M. Smits, W. Spence, et al., “Dim Light Melatonin Onset (DLMO): A Tool for the Analysis of Circadian Phase in Human Sleep and Chronobiological Disorders,” Progress in Neuro-Psychopharmacology & Biological Psychiatry, Vol. 31, No. 1, 2007, pp. 1-11. http://dx.doi.org/10.1016/j.pnpbp.2006.06.020
- A. J. Lewy, V. K. Bauer, S. Ahmed, K. H. Thomas, N. L. Cutler, C. M. Singer, et al., “The Human Phase Response Curve (PRC) to Melatonin is about 12 h out of Phase with the PRC to Light,” Chronobiology International, Vol. 15, No. 1, 1998, pp. 71-83. http://dx.doi.org/10.3109/07420529808998671